Related Experiment Video
Updated: Jul 11, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
P300 plays a role in p16(INK4a) expression and cell cycle arrest
1Institute of Genetics and Cytology, Northeast Normal University, Changchun, China.
Abstract:
As a cyclin-dependent kinase inhibitor, p16(INK4a) plays a key role in cell cycle progression and cellular differentiation, and its expression is frequently altered in human cancers through epigenetically mediated transcriptional silencing. In this report, we demonstrate that p300 was able to induce cell cycle arrest, and this process was reversed by p16(INK4a) silencing by RNA interference in HeLa cells. We also show that p300 was involved in activation of p16(INK4a) expression in 293T cells. Specifically, p300 cooperated with Sp1 to stimulate both p16(INK4a) promoter activity and mRNA expression. Co-immunoprecipitation and mammalian two-hybrid assays revealed that p300 and Sp1 formed a complex through interaction between the Q domain of p300 and the N-terminal domain of Sp1. The chromatin immunoprecipitation assays verified that p300 was recruited to p16(INK4a) promoter, and the histone acetyltransferase domain of p300 participated in p16(INK4a) activation through inducing hyperacetylation of histone H4 at p16(INK4a) gene. These data suggest that p300 plays a critical role in transcriptional regulation of p16(INK4a) and in cell cycle arrest.
Insights
The protein p300 activates the p16INK4a gene, which is crucial for cell cycle arrest. This activation involves p300 binding to the p16INK4a promoter and modifying histones, impacting cancer development.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- p16INK4a is a cyclin-dependent kinase inhibitor vital for cell cycle control and differentiation.
- Altered p16INK4a expression, often via epigenetic silencing, is common in human cancers.
Purpose of the Study:
- To investigate the role of p300 in regulating p16INK4a expression and its impact on cell cycle arrest.
- To elucidate the molecular mechanisms by which p300 controls p16INK4a transcription.
Main Methods:
- RNA interference (RNAi) for p16INK4a silencing in HeLa cells.
- Co-immunoprecipitation and mammalian two-hybrid assays to study protein interactions.
- Chromatin immunoprecipitation (ChIP) assays to assess p300 recruitment and histone modifications at the p16INK4a promoter.
Main Results:
- p300 induced cell cycle arrest, which was reversed by p16INK4a silencing.
- p300 activated p16INK4a expression by cooperating with Sp1 at the promoter.
- p300 and Sp1 form a complex; p300 is recruited to the p16INK4a promoter.
- p300's histone acetyltransferase activity led to histone H4 hyperacetylation, activating p16INK4a.
Conclusions:
- p300 plays a critical role in the transcriptional regulation of p16INK4a.
- p300-mediated activation of p16INK4a contributes to cell cycle arrest.
- These findings highlight a novel regulatory pathway for p16INK4a with implications for cancer research.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation

